Drug Type siRNA |
Synonyms- |
Target |
Action inhibitors |
Mechanism WWTR1 inhibitors(WW domain containing transcription regulator 1 inhibitors), YAP1 inhibitors(Yes1 associated transcriptional regulator inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metabolic dysfunction-associated steatotic liver disease | Preclinical | Japan | 07 May 2025 |





